George Paletta, Jr.

Director at Longeveron.

Earliest Form D on file: Mar 2026

Filed Mar 25, 2026

Longeveron

Bone marrow cell therapy for heart defects and frailty

Biotech, Miami FL

Named, Director.

$15.89M

sold of $33.515M offered

Network

At Longeveron

9 people

Lisa A. Locklear
Executive Officer, signed as Chief Financial Officer
Joshua M. Hare
Executive Officer, Director
Devin Blass
Executive Officer
Nataliya Agafonova
Executive Officer
Paul Lehr
Executive Officer
Rock Soffer
Director

3 more at Longeveron